Form 4: Surgery Partners CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Surgery Partners CEO Jason Eric Evans sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.
Summary
- Surgery Partners CEO Jason Eric Evans sold 1,984 shares of common stock on March 11, 2024, at a weighted average price of $29.44.
- He also sold 4,840 shares of common stock on March 13, 2024, at a weighted average price of $29.71.
- These sales were to satisfy tax withholding obligations related to the vesting of restricted stock.
- Following these transactions, Evans directly owns 459,670 shares of Surgery Partners common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently indicate positive or negative sentiment.
Industry Context
Sales of shares by company executives to cover tax obligations upon vesting of restricted stock are a common practice.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders due to the slight dilution of shares.
Key Dates
| Date | Description |
|---|---|
| 03/10/2024 | Vesting of restricted stock leading to tax withholding obligations. |
| 03/11/2024 | Sale of 1,984 shares of common stock at $29.44. |
| 03/13/2024 | Sale of 4,840 shares of common stock at $29.71. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.